Add BrightSurf on Google Email

American Association for Cancer Research


Many patients diagnosed with adenomas may not receive colonoscopies in recommended time frame

A recent study published in Cancer Epidemiology, Biomarkers & Prevention found that many patients diagnosed with adenomas often do not receive subsequent colonoscopies within the recommended time frame. The study analyzed patterns and factors associated with the receipt of colonoscopy within approximately three years of a diagnosis of ...

Deep learning can distinguish recalled-benign mammograms from malignant and negative images

A deep learning approach can identify nuanced mammographic imaging features specific to recalled but benign (false-positive) mammograms, distinguishing them from those identified as malignant or negative. The study achieved an area under the curve (AUC) of 0.76-0.91, indicating high performance in detecting false recalls.

SourceAmerican Association for Cancer Research·JournalClinical Cancer Research·DateOct 11, 2018

Older melanoma patients may respond to anti-PD1 immunotherapy better than younger patients

A recent study published in Clinical Cancer Research found that older melanoma patients are more likely to respond to anti-PD1 immunotherapy compared to younger patients. Researchers analyzed data from 538 patients with melanoma treated with pembrolizumab and found a 13% decrease in progression rates for each decade of life.

SourceAmerican Association for Cancer Research·JournalClinical Cancer Research·DateJun 13, 2018

Tau mutations may increase cancer risk

Researchers discovered that tau protein mutations can increase cancer risk by up to 3.72 times, highlighting a new association between neurodegenerative disorders and cancer. The study's findings suggest that clinicians should monitor patients with tau mutations for their cancer risk, in addition to attending to neurodegeneration.

SourceAmerican Association for Cancer Research·JournalCancer Research·DateMay 24, 2018

Potential cognitive effects of targeted drugs in children may be reversible with therapy

A study found that targeted cancer drugs can cause cognitive and behavioral deficits in young mice, but these effects can be reversed with environmental stimulation and physical exercise. Researchers suggest that pediatric brain cancer patients may experience similar side effects, highlighting the need for remediation efforts.

SourceAmerican Association for Cancer Research·JournalCancer Research·DateMar 20, 2018

Mutational signatures may ID pts with Br Ca most likely to benefit from platinum-based chemo

Researchers identified mutational signatures characteristic of homologous recombination deficiency (HRD) as associated with improved clinical outcomes to platinum-based chemotherapy. High HRDetect scores were significantly linked to radiographic tumor shrinkage and longer overall survival in patients treated with the medication.

SourceAmerican Association for Cancer Research·JournalClinical Cancer Research·DateDec 18, 2017

Urban American-Indian, Alaskan natives may have lower survival following invasive cancer

The study found that urban American-Indian and Alaskan Native individuals had a higher risk of mortality from prostate and breast cancer, with AIANs facing an 87% increased risk for prostate cancer-specific mortality. The community's unique history of social and environmental injustices may be contributing to these disparities.

SourceAmerican Association for Cancer Research·JournalCancer Research·DateNov 29, 2017